Plus Therapeutics, Inc.
|
(b)
|
Address of Issuers Principal Executive Offices:
|
4200 Marathon Blvd., Suite 200
Austin, Texas 78756
(a)
|
Name of Person Filing:
|
This statement is jointly filed by and on behalf of each of Schonfeld Strategic Advisors LLC, a Delaware limited liability company
(Schonfeld) and Sassicaia Capital Advisers LLC, a Delaware limited liability company (Sassicaia, together with Schonfeld, the Reporting Persons).
Schonfeld may be deemed to indirectly beneficially own securities owned by a separate managed account (the Schonfeld
Account). The Schonfeld Account is the record and direct beneficial owner of the securities covered by this statement that are listed in the Information Page for Schonfeld.
Sassicaia is an investment adviser for a separate managed account (the Sassicaia Account) and may be deemed to
indirectly beneficially own securities owned by the Sassicaia Account. The Sassicaia Account is the record and direct beneficial owner of the securities covered by this statement that are listed in the Information Page for Sassicaia.
Schonfeld and the Schonfeld Account disclaim beneficial ownership of the shares held by the Sassicaia Account. Sassicaia and the Sassicaia
Account disclaim beneficial ownership of the shares held by the Schonfeld Account.
Each Reporting Person declares that neither the filing
of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner of any securities covered by this statement.
Each Reporting Person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for the purpose of
Section 13(d) or 13(g) of the Act. Each of the Reporting Persons declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purpose of Section 13(d) or 13(g) of
the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of
the issuer or otherwise with respect to the issuer or any securities of the issuer or (ii) a member of any group with respect to the issuer or any securities of the issuer.
(b)
|
Address of Principal Business Office or, if None, Residence:
|
The address of the principal business office of Schonfeld is 460 Park Avenue, New York, New York, 10022.